Sales and Marketing

Showing 15 posts of 11524 posts found.

Stability data issue holds up Adventrx cancer drug

March 3, 2010 Manufacturing and Production, Sales and Marketing Adventrx, Cancer, vinorelbine

US drugmaker Adventrx Pharmaceuticals has had the marketing application for its cancer drug ANX-530 (vinorelbine emulsion) rejected by the US …
OSI Pharmaceuticals

Astellas moves in on OSI Pharmaceuticals

March 2, 2010 Sales and Marketing Astellas, Astellas Pharma Europe, OSI

Astellas has launched a hostile takeover bid for OSI Pharmaceuticals, going directly to stockholders with a proposal that values the US …

Merck shows off expanded pipeline

March 2, 2010 Sales and Marketing Merck, Schering-Plough

Merck has put its new pipeline on display for the first time since its October merger with Schering-Plough was completed. …

Shire launches Vpriv to capitalise on Genzyme woes

March 2, 2010 Sales and Marketing Cerezyme, Gaucher's, Shire

Shire has gained US approval to launch Vpriv, its new treatment for Gaucher’s disease, which it hopes will steal market …
ResearchPartnershipDavidWhite

David White joins The Research Partnership

March 2, 2010 Sales and Marketing The Research Partnership, appointment, sales and marketing

The Research Partnership has appointed David White director of syndicated services. Based in London, David will oversee the development and …
Brazil

Emerging Markets: finding your way in a Brave New World

March 1, 2010 Sales and Marketing Brazil, China, India, Russia, em, emerging markets, sales, sales force effectiveness

Ask almost any pharmaceutical marketer where the future growth lies for the industry, and the answer will be almost certainly …

Pfizer’s Kristin Peck gains business development role

March 1, 2010 Sales and Marketing Pfizer, appointment, sales and marketing

Kristin Peck has been appointed senior vice president, worldwide business development, strategy and innovation at Pfizer. She succeeds William Ringo …

Alimta recommended as maintenance therapy

March 1, 2010 Sales and Marketing Alimta, Cancer, NSCLC, lilly

 NICE has recommended Alimta as a maintenance treatment for people with locally advanced or metastatic non-small cell lung cancer. Patients …

Sanofi’s BSI-201 tipped for success in triple negative breast cancer

February 28, 2010 Sales and Marketing Cancer, PARP, Sanofi, breast cancer

 Sanofi-Aventis’s BSI-201 will garner sales of $1.7 billion in the triple negative breast cancer drug market in 2018, according to …

Zeltia continue strong growth

February 26, 2010 Sales and Marketing 2009 financials, PharmaMar, Yondelis, Zeltia

Consolidated revenues at Spanish biopharmaceutical company Zeltia increased by 17% to 123.4 million euros enabling it to halve operating losses. …

Bayer pharma sales overcome European decline

February 26, 2010 Sales and Marketing 2009 financials, Bayer, Xarelto

Bayer’s group sales dropped 5% to 31 billion euros in a “difficult year” for the company that saw a drop …

GSK hits back at Avandia safety probe

February 25, 2010 Sales and Marketing Avandia, diabetes

GlaxoSmithKline has hit back at allegations from US Senators that its diabetes drug Avandia raises the risk of heart attacks, …

Sanofi’s breast cancer candidate tipped for future success

February 25, 2010 Research and Development, Sales and Marketing BSI-201, Sanofi-Aventis, breast cancer

A Sanofi-Aventis drug currently in phase III has been predicted as a future blockbuster in breast cancer treatment. Sanofi’s BSI-201 …
DConnelly

GSK’s Deidre Connelly named Woman of the Year

February 25, 2010 Sales and Marketing GlaxoSmithKline, HBA, appointment, sales and marketing

The Healthcare Businesswomen’s Association has named Deidre Connelly its 2010 Woman of the Year. Connelly is president of North America …

New starters at Double Helix

February 25, 2010 Sales and Marketing Double Helix, appointment, sales and marketing

Healthcare consultancy Double Helix has appointed Amanda Siebols (pictured) as a research consultant and Ioanna Maraki as a research executive. …
The Gateway to Local Adoption Series

Latest content